NEK2 and hepatocellular carcinoma: Moreover, the anti-NEK2 mAb was co-cultured with hepatocellular carcinoma (HCC) cells to investigate its effect on the proliferation of HCC cells and to provide a basis for NEK2-targeted drug research.